Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 08 December 2016

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Distance From a Transplant Center is associated with receipt of liver transplant and survival

This week's issue of the Journal of the American Medical Association examines the association of distance from a transplant center with access to waitlist placement, receipt of liver transplantation, and survival among US veterans.

News image

Importance  Centralization of specialized health care services such as organ transplantation and bariatric surgery is advocated to improve quality, increase efficiency, and reduce cost.

The effect of increased travel on access and outcomes from these services is not fully understood.

Dr David Goldberg and colleagues from Philadelphia, USA evaluated the association between distance from a Veterans Affairs (VA) transplant center (VATC) and access to being waitlisted for liver transplantation, actually having a liver transplant, and mortality.

The team performed a retrospective study of veterans meeting liver transplantation eligibility criteria from 2003 until 2010, using data from the Veterans Health Administrationís integrated, national, electronic medical record linked to Organ Procurement and Transplantation Network data.

The team's primary outcome was being waitlisted for transplantation at a VATC.

Secondary outcomes included being waitlisted at any transplant center, undergoing a transplantation, and survival.

From 2003-2010, 50,637 veterans were classified as potentially eligible for transplant.

11% were waitlisted at any transplant center
Journal of the American Medical Association

The team noted that 6% were waitlisted and 49% of those were waitlisted at 1 of the 5 VATCs.

Of 3417 veterans receiving care at a VA hospital located within 100 miles from a VATC,

The team observed that 7% were waitlisted at a VATC, and 11% at any transplant center.

Of 47,219 veterans receiving care at a VA hospital located more than 100 miles from a VATC, 3% were waitlisted at a VATC, and 5% at any transplant center.

In multivariable models, the researchers found that increasing distance to closest VATC was associated with significantly lower odds of being waitlisted at a VATC or any transplant center.

For example, the researchers found that a veteran living 25 miles from a VATC would have a 7% adjusted probability of being waitlisted, whereas a veteran 100 miles from a VATC would have a 6% adjusted probability.

In adjusted models, increasing distance from a VATC was associated with significantly lower transplantation rates.

The researchers found a significantly increased mortality among waitlisted veterans from the time of first hepatic decompensation event in multivariable survival models.

For example, a waitlisted veteran living 25 miles from a VATC would have a 63% 5-year adjusted probability of survival from first hepatic decompensation event compared with a 60% 5-year adjusted probability of survival for a veteran living 100 miles from a VATC.

Dr Goldberg and team conclude, "Among VA patients meeting eligibility criteria for liver transplantation, greater distance from a VATC or any transplant center was associated with lower likelihood of being waitlisted, receiving a liver transplant, and greater likelihood of death."

"The relationship between these findings and centralizing specialized care deserves further investigation."

JAMA 2014; 311(12): 1234-1243
28 March 2014

Go to top of page Email this page Email this page to a colleague

 08 December 2016 
Intestinal tuberculosis vs Crohn's disease
 08 December 2016 
Precision medicine in IBD
 08 December 2016 
Preterm birth in women with IBD
 07 December 2016 
Iron deficiency in ulcerative colitis
 07 December 2016 
IBD source of information and patient education
 07 December 2016 
End-of-rotation resident transition and in-hospital mortality
 06 December 2016 
Anti-TNF therapy for IBD
 06 December 2016 
Crohn's disease and thyroid cancer risk
 06 December 2016 
IBD Disability Index in restorative proctocolectomy
 05 December 2016 
Reducing hospitalization in IBD
 05 December 2016 
Disease mangement in IBD
 05 December 2016 
New biomarkers for IBD diagnosis
 02 December 2016 
Hep E in acute liver failure
 02 December 2016 
Occurrence and severity of alcoholic hepatitis
 02 December 2016 
Food antigen in active eosinophilic esophagitis
 01 December 2016 
Iron deficiency in anemic ulcerative colitis patients
 01 December 2016 
Prognostic factors after paracetamol-induced liver failure
 01 December 2016 
Factors that influence colorectal cancer screening findings
 30 November 2016 
Certolizumab pegol in Crohn's disease
 30 November 2016 
Genetic risk of Crohn's in chronic granulomatous disease
 30 November 2016 
Rifaximin in diarrhea-predominant IBS
 29 November 2016 
Assessing liver steatosis
 29 November 2016 
Colorectal cancer surveillance in ulcerative colitis
 29 November 2016 
Treating Zenker's diverticulum
 28 November 2016 
Complications in celiac disease
 28 November 2016 
Monitoring IBD with mobile technology
 28 November 2016 
Reducing warfarin-related upper GI bleeds
 25 November 2016 
Metal vs plastic stents for pancreatic cancer surgery
 25 November 2016 
Yoga and IBS therapy 
 25 November 2016 
Colorectal cancer screening issues
 24 November 2016 
Partner burden in celiac disease
 24 November 2016 
Fusobacterium nucleatum for colorectal cancer prognosis
 24 November 2016 
PPIS and gastric cancer risk
 23 November 2016 
Quality assurance standards for colonoscopy
 23 November 2016 
Diagnosing autoimmune pancreatitis
 23 November 2016 
Readmissions in cirrhosis
 22 November 2016 
Bile acid diarrhea in function bowel disorder with diarrhea
 22 November 2016 
Fatigue in IBD
 22 November 2016 
PPIs and C. diff in ICU 
 21 November 2016 
Pain after endoscopic resection of gastric tumors
 21 November 2016 
Antivirals and chemotherapy in Hep C patients with cancer
 21 November 2016 
Financial incentives and colorectal cancer screening
 18 November 2016 
Colorectal cancer risk and self-reported family history
 18 November 2016 
Ustekinumab in Crohnís disease
 18 November 2016 
Antivirals and chemotherapy in Hep C patients with cancer
 17 November 2016 
Liver-related specialty care in patients with Hep C
 17 November 2016 
Risk of overweight in infants
 17 November 2016 
Moderate alcohol consumption and NAFLD
 16 November 2016 
PPI therapy in liver disease
 16 November 2016 
Education in Gastroenterology fellowship
 16 November 2016 
Paternal preconceptional use of anti-TNF-α agents
 15 November 2016 
Novel treatment of NASH 
 15 November 2016 
Contraceptives and ulcerative colitis
 15 November 2016 
Physician perspectives on Hep C management
 14 November 2016 
Cardiovascular risk in NAFLD 
 14 November 2016 
Vit D and NAFLD
 14 November 2016 
Malignancy risk in IBD 
 11 November 2016 
Treatment of Hep C along with opioid agonist therapy
 11 November 2016 
Diabetes and liver cancer risk in Hep C cirrhosis
 11 November 2016 
Biomarker of cirrhosis progression

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2016 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us